| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 38,837 | 49,604 | 48,318 | 89,046 |
| Cost of biosecurity revenue-Biosecurity | 8,177 | - | - | - |
| Cost of biosecurity revenue-Other Revenue | 4,625 | - | - | - |
| Research and development | 69,353 | 53,370 | 70,923 | - |
| General and administrative | 44,954 | 43,279 | 49,043 | - |
| Cost of biosecurity revenue-Product And Service Other | - | 5,380 | - | - |
| Goodwill impairment | 0 | 0 | - | - |
| Cost of biosecurity revenue | - | - | 12,047 | - |
| Cost of biosecurity revenue-Biosecurity Segment | - | 9,442 | - | - |
| Restructuring charges | 1,745 | 3,674 | 5,273 | - |
| Total operating expenses | 128,854 | 115,145 | 137,286 | 144,250 |
| Loss from operations | -90,017 | -65,541 | -88,968 | -55,204 |
| Interest income, net | 5,742 | 6,083 | 6,081 | - |
| Gain (loss) on investments | 3,684 | -229 | -3,693 | -6,912 |
| Interest income, net | - | - | - | -9,251 |
| Loss on deconsolidation of subsidiary | 0 | - | - | - |
| Deconsolidation, gain (loss), amount | - | - | - | -7,013 |
| Change in fair value of warrant liabilities | 0 | 0 | - | -1,528 |
| Other income (expense), net | -163 | -896 | -4,289 | 1,572 |
| Total other income (expense) | 9,263 | 4,958 | -1,901 | -1,574 |
| Loss before income taxes | -80,754 | -60,583 | -90,869 | -56,778 |
| Income tax (benefit) expense | 1 | -283 | 88 | -375 |
| Net loss | -80,755 | -60,300 | -90,957 | -56,403 |
| Foreign currency translation adjustment | 27 | 2,586 | - | 494 |
| Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary | 0 | - | - | -1,492 |
| Debt securities, available-for-sale, unrealized gain (loss) | - | -83 | - | - |
| Unrealized gains (loss) on available-for-sale securities | 316 | - | - | - |
| Total other comprehensive income (loss) | - | - | - | 1,986 |
| Total other comprehensive (loss) income | 343 | 2,503 | - | - |
| Comprehensive loss | -80,412 | -57,797 | - | -54,417 |
| Basic (in shares) | 55,633,718 | 54,858,982 | 54,241,619 | 52,240,000 |
| Diluted (in shares) | 55,633,718 | 54,858,982 | 54,241,619 | 52,246,000 |
| Net loss per share, basic (in dollars per share) | -1.45 | -1.1 | -1.68 | -1.08 |
| Net loss per share, diluted (in dollars per share) | -1.45 | -1.1 | -1.68 | -1.08 |
Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA)